MBL2 and Stroke: Low systemic levels of mannose-binding lectin were associated with smaller infarction size and favorable outcome in ischemic stroke patients [21] and high plasma C3 levels at three months after stroke due to large vessel disease (LVD) were associated with unfavorable outcome at this time point and after two years post-stroke [26].